‘What about vaping?’ Exploring the facilitators and barriers experienced by health professionals in offering vaping cessation support − a scoping review
Abstract
Objectives and importance of study To summarise current evidence on the facilitators and barriers to offering vaping cessation support from the perspective of health professionals (HPs) with client-facing roles. Study type A scoping review following the Joanna Briggs Institute methodology. Methods Six databases were searched for relevant peer-reviewed articles published in English between 2003 and 2024. All articles were screened by two reviewers independently, based on pre-specified eligibility criteria. Data extraction and analyses were informed by the Theoretical Domains Framework (TDF). Results A total of 10,992 articles were screened; 21 publications met the inclusion criteria. Data extracted were mapped to the TDF (12 of the 14 domains were used). Barriers were more commonly reported than facilitators and included lack of knowledge, lack of training and competing priorities; the most commonly reported facilitators were HPs' sense of responsibility and willingness to provide e-cigarette cessation support. Most of the studies included were from the US and employed quantitative surveys. Most of the studies screened focused on the utility of e-cigarettes as cessation aids for combustible tobacco smoking, highlighting a gap in the interventional evidence on e-cigarette cessation. Conclusions More primary qualitative studies, including in Australia, are needed to understand the complexities of offering vaping cessation support. Although a range of HPs were represented in the…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.